The UK-based consumer healthcare company will be modernizing its facility along Brook Road, where it conducts R&D for such ...

Based in the United Kingdom, Haleon makes consumer health care products, including Advil, Centrum Multivitamin and Aquafresh ...

The analyst's commentary reflects careful consideration of Haleon's latest guidance and market conditions, particularly the ...

Jefferies reiterated its Buy rating on Haleon PLC (HLN:LN) (NYSE: HLN), maintaining a price target of GBP4.50. Currently ...

Companies say they are working to update their products to comply with the Food and Drug Administration's decision ...

On Jan 15, Pfizer Inc. ( PFE, Financial) announced to sale of about 700 million ordinary shares of Haleon plc through a ...

Pfizer recently announced that it has sold 700 million shares of Haleon for $3.05 billion. Haleon was formed in 2019 by merging the Pfizer’s and GSK’s consumer healthcare business. After the r ...

Once complete, Pfizer's stake in Haleon will fall from 15.0% to around 7.3%. Pfizer's move comes after Haleon's spin-off as an independent consumer healthcare company, part of plans to reshape its ...

Pfizer will lower its stake in Haleon from 15 percent to about 7.3% by selling shares worth 2.50 billion pounds ($3.05 billion) in the British consumer healthcare company, JPMorgan said. The sale ...